Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$820M |
| 2 |
Microsoft
MSFT
|
+$811M |
| 3 |
McDonald's
MCD
|
+$804M |
| 4 |
Coca-Cola
KO
|
+$655M |
| 5 |
Amazon
AMZN
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.64B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.1B |
| 3 |
Strategy Inc
MSTR
|
+$564M |
| 4 |
Kroger
KR
|
+$558M |
| 5 |
Danaher
DHR
|
+$494M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.33% |
| 2 | Healthcare | 3.23% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Financials | 2.55% |
| 5 | Industrials | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5601
ImmunityBio
IBRX
$8.39B
| $2.08M | ﹤0.01% |
786,225
+307,902
| +64% | +$828K |
|
5602
ATN International
ATNI
$486M
| $2.07M | ﹤0.01% |
127,661
-27,091
| -18% | -$441K |
|
|
VMEO
5603
DELISTED
Vimeo
VMEO
| $2.07M | ﹤0.01% |
512,985
+218,878
| +74% | +$1.01M |
|
5604
CALL
Americold
COLD
$4.14B
| $2.07M | ﹤0.01% |
124,600
+95,100
| +322% | +$1.72M |
|
5605
Tyra Biosciences
TYRA
$1.56B
| $2.07M | ﹤0.01% |
216,136
+119,854
| +124% | +$1.14M |
|
|
GPGI
5606
CALL
GPGI Inc
GPGI
$3.82B
| $2.07M | ﹤0.01% |
146,800
+46,300
| +46% | +$568K |
|
|
CSW
5607
CALL
CSW Industrials
CSW
$5.58B
| $2.07M | ﹤0.01% |
7,200
+900
| +14% | +$272K |
|
|
MREO
5608
Mereo BioPharma
MREO
$49.1M
| $2.06M | ﹤0.01% |
760,659
+417,006
| +121% | +$1.01M |
|
5609
Fidelity Value Factor ETF
FVAL
$1.36B
| $2.06M | ﹤0.01% |
32,237
-10,876
| -25% | -$651K |
|
5610
CALL
Equitable Holdings
EQH
$13.9B
| $2.06M | ﹤0.01% |
36,700
+1,900
| +5% | +$97.7K |
|
|
BCAX
5611
Bicara Therapeutics
BCAX
$1.65B
| $2.06M | ﹤0.01% |
+221,516
| New | +$2.64M |
|
5612
CALL
Roundhill N-100 0DTE Covered Call Strategy ETF
QDTE
$975M
| $2.06M | ﹤0.01% |
57,900
+42,900
| +286% | +$1.42M |
|
5613
CALL
Travere Therapeutics
TVTX
$5.99B
| $2.05M | ﹤0.01% |
138,800
+14,300
| +11% | +$237K |
|
5614
PUT
Kodak
KODK
$976M
| $2.05M | ﹤0.01% |
363,300
-110,000
| -23% | -$661K |
|
5615
FlexShares Ultra-Short Income Fund
RAVI
$1.5B
| $2.05M | ﹤0.01% |
27,152
-51,339
| -65% | -$3.86M |
|
5616
Global X MLP ETF
MLPA
$2.34B
| $2.05M | ﹤0.01% |
40,764
+38,542
| +1,735% | +$1.92M |
|
5617
CALL
Ituran Location and Control
ITRN
$1.04B
| $2.04M | ﹤0.01% |
52,800
+41,700
| +376% | +$1.5M |
|
5618
PUT
Sensata Technologies
ST
$6.68B
| $2.04M | ﹤0.01% |
67,900
-40,900
| -38% | -$1M |
|
5619
iShares Russell 2500 ETF
SMMD
$3.86B
| $2.04M | ﹤0.01% |
30,139
+8,206
| +37% | +$520K |
|
5620
CALL
Xponential Fitness
XPOF
$215M
| $2.04M | ﹤0.01% |
272,600
-53,300
| -16% | -$442K |
|
5621
B&G Foods
BGS
$280M
| $2.04M | ﹤0.01% |
482,617
+283,183
| +142% | +$1.48M |
|
|
AGNT
5622
AGNT Inc
AGNT
$710M
| $2.04M | ﹤0.01% |
224,273
+133,786
| +148% | +$1.17M |
|
5623
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$782M
| $2.04M | ﹤0.01% |
69,916
+59,695
| +584% | +$1.7M |
|
5624
Arcutis Biotherapeutics
ARQT
$3.22B
| $2.04M | ﹤0.01% |
145,493
-164,582
| -53% | -$2.31M |
|
5625
PUT
Vanguard Morningstar Small-Cap ETF
VB
$83.2B
| $2.04M | ﹤0.01% |
8,600
-5,800
| -40% | -$1.29M |
|
Similar funds
Ken Griffin's Q2 2025 Portfolio in Review
As of Q2 2025, Ken Griffin held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ken Griffin withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Walmart Inc worth $401M.
- Ken Griffin's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
- Ken Griffin added most to NVIDIA in Q2 2025, an estimated $820M increase.
- Ken Griffin's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
- Ken Griffin fully exited Kroger in Q2 2025, selling an estimated $558M.
- Ken Griffin's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
- Ken Griffin opened 1,459 new positions and closed 3,524 in Q2 2025.
- Ken Griffin's portfolio value rose 9.2% quarter-over-quarter to $576B.
Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.